Excellent work, Nice Design https://www.elbacsolar.com/wwwbio-apode-almased-909f.pdf bio-apo.de  "The strength in the quarter was licenses. They had a verygood license quarter and that's kind of front and center forinvestors," Ives said. "It seems the company is poised to see anice reacceleration in license revenue heading into 2014."